— Events —
Ketamine-Assisted Psychotherapy Group
11/30/20 — 2:00 p.m. - 5:00 p.m.
1 Bodega Ave. “Studio One”
Petaluma CA 94952
Followup Integration Group by Zoom — Tuesday evening 12/1/20 — time to be arranged
Fee for KAP group & integration group: $525
Facilitated by Jessica McIninch, PsyD and Carl Spitzer, MD
Temenos is offering a ketamine-assisted psychotherapy group. Group therapy with ketamine is a profound way to further the benefits of ketamine therapy as it blends the deep internal dive into resilience that KAP clients are familiar with, with an opportunity to connect with like-minded others. This can help open new areas of awareness and deepen trust, as well as offer an opportunity to meet people who are on a similar path. Participants must be experienced with KAP.
Being part of a ketamine group can be a vulnerable experience. Our staff appreciates this vulnerability and does everything possible to create a safe place, on both physical and psychological levels. Safety protocols include: COVID-related, physical space considerations, confidentiality guidelines, management of psychological space so that no one need share anything that feels too vulnerable, and a follow-up group to help integrate the experience.
Of course there is no ultimate safety, except perhaps through a sense of being profoundly interconnected. As we feel increasingly stable in ourselves, we can accept the truth of our vulnerability and decide to live fully anyway. It is a commitment to this kind of living that allows us to step into a group such as this. And stepping in leads in turn to an increase in interconnectedness and thus increases our sense of safety in the world.
Maximum of 4 participants
All participants and staff will wear masks
Studio One is a large room with good ventilation
A HEPA-quality air purifier will be utilized
Anyone symptomatic or having been exposed to COVID within the prior week cannot attend
A medical check will be administered upon entering
Follow-up Integration Session will be via Zoom
Weekly KAP Integration Group
Temenos provides a weekly integration group for clients who have previously participated in ketamine-assisted psychotherapy. This group provides clients the opportunity to benefit from ongoing, depth-oriented integration work in a safe, consistent setting with peers interested in deepening the insights achieved in medicine sessions.
For more information contact Jessica.
Ketamine Training for Clinicians
Four-part didactic training (via Zoom):
Mondays from 7:00 p.m. to 8:30 p.m. — 1/11/21, 1/18/21, 1/25/21 & 2/1/21.
Fee: $500 (Plus $17.50 administration if paid by credit card)
Presenters: Carl Spitzer, MD; Christina Ingenito, LCSW; Jessica McIninch, PsyD; Jim Matto-Shepard, PhD (presenter bios)
Temenos is offering a four-part online training in ketamine-assisted psychotherapy (KAP) for clinicians and interns. The modules will be live on four successive Monday nights and will be recorded for participants who cannot attend at the time of the presentation.
Experiential Training will be available upon completion of this didactic training or the equivalent (as determined by the Temenos Training Coordinator).
Temenos ketamine-assisted psychotherapy (KAP) training is designed to train psychotherapists to become competent beginning-level providers for KAP. It will also serve as a foundational course for medical professionals who want to be part of a treatment team for KAP. The training is set within the context of psychedelic-assisted psychotherapy (PAP) as a healing modality for our culture. Participants will learn not only about ketamine as a stand alone medicine and one that facilitates psychotherapy, but will also increase awareness and skills for psychedelic-assisted psychotherapy in general. To optimize retention of complex information, the didactic portion of the course will be taught in four 90-minute sections over four weeks.
This training discusses ketamine when used as an adjunct to psychotherapy for therapeutic reasons. These include three basic categories: for a psychiatric indication such as treatment resistant depression or suicidality, for the facilitation of psychological work (psycholytic), and for psycho-spiritual exploration.
The Historical, Cultural & Medical Context of KAP
The importance of context or story
Set and Setting
The cultural and historical context of psychedelics
Clinical work with non-ordinary states
The cultural and historical context of ketamine
Ketamine as the poor step-child of psychedelics
Legality and prescribing off-label
The many Flavors of K
Subjective experiences with ketamine
Ketamine — “medicine,” a tool to facilitate psychotherapy, or a psychedelic? Are these all aspects of the same thing?
Different approaches to KAP, infusion w/o much psychotherapy to psycholytic with an emphasis on psychotherapy
the experiential differences between troches, rapid dissolving tablets, nasal sprays, IM and IV ketamine. (what about suppositories?)
Differential diagnosis — who is KAP appropriate for?
Ketamine as a medicine for treatment-resistant depression and suicidality
Is it appropriate to do psychedelic work with “well” people in clinic?
Dosages based on the goals of treatment
The therapeutic team — roles and responsibilities
Relevant Psychophysiology of KAP and Clinic Setup
Chemistry and pharmacological mechanisms and how they relate to the phenomenology of ketamine.
Dosages, route of administration and bioavailability
Physical dangers & medical contraindications
Managing psychiatric emergencies
What are potential side-effects and how are they treated
How to determine appropriate route and dose
Variables in how to order and store injectable & sublingual ketamine
Legal issues and the MD/psychotherapist alliance
Setting up an office
Group/ At home lozenges/ COVID/ Couples and more
The process of KAP
Intake variables — diagnosis and client selection
Clarifying intention with the client
Creating the psycho-spiritual space for the session
Monadic versus dyadic treatment
Administration of ketamine, how and by whom
How to be in the unfolding session — different roles
Transference, boundaries and therapeutic “cleanliness”
Integration — where the rubber meets the road
When to refer out
For more information about this training contact us here or call us at 707-992-5015.
Experiential Ketamine Training
This two-day experiential training for ketamine-assisted psychotherapy (KAP) is for licensed clinicians and experienced interns. The training will build on Temenos didactic KAP training and provide entry-level skills for working as a KAP provider. This training supports the skills and mindset for becoming a psychedelic-assisted psychotherapist.
This training will provide clinicians an understanding of the subjective and therapeutic effects of ketamine-assisted psychotherapy from the inside out. The emphasis will be on creating intention, setting the stage, monitoring the client for safety, working verbally on ketamine, and integration.
Clinicians will have the opportunity to both practice the skill of being a ketamine-assisted psychotherapist and to be a client receiving initial treatment. Participants will work in pairs, with each being a client one day and a therapist on the other. All ketamine sessions will be low dose using sublingual lozenges.
• Integrate knowledge about providing KAP in a clinic setting
• Develop skill in the practice of KAP
• Understand the therapeutic benefits of ketamine
• As a tool for psychodynamic exploration
• To build mindfulness & awareness of the body
• To strengthen a sense of inner resourcefulness
Completion of Temenos, didactic Ketamine-Assisted Psychotherapy training (above) is a prerequisite for this training.
COVID Safety: In this experiential KAP training, we balance the need for in-person supervision and training with COVID safety by using a combination of in-person dyads and Zoom supervision.
For questions about the clinical procedures outlined here, contact Jim at 707-762-1670 or email@example.com. For questions about enrollment, contact Alison at firstname.lastname@example.org.
It should be noted that enrollment in this training is not a guarantee for acceptance. Should a participant fail to qualify for the training, fees paid for the course will be fully refunded.
Dates and Times:
Saturday February 27, 2021 10:00 a.m. to 2:00 p.m.
Saturday March 6, 2021 10:00 a.m. to 2:00 p.m.
Trainers: Carl Spitzer MD & Jim Matto-Shepard, PhD
~ Links ~
Links to Websites of Colleagues
Reference Material on Ketamine
Reference Material on MDMA